Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3155069b833b184bcd4ad12f7100dd4c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-56 |
filingDate |
2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caf5e522673d97cdfee0eeb9cdca3c07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f6e4066133e3544245bbf923e7074d |
publicationDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-107922334-A |
titleOfInvention |
Polycyclic Indoline and Indolenine Compounds |
abstract |
The present invention relates to indoline and indolenine alkaloid compounds. In particular, the indoline and indolenine alkaloid compounds of the present invention have antimicrobial activity and/or are capable of resensitizing methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics. The invention also relates to processes for the preparation of said compounds and uses of said compounds. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108864107-A |
priorityDate |
2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |